InvestorsHub Logo
icon url

Inoviorulez

02/05/17 5:14 PM

#1133 RE: fishhunter #1132

Oh it will, the reason why funds haven't gotten in yet is because the contract hasn't been signed yet. Novartis has until October 2017 after the phase 2b trial starts to decide. I don't believe that Novartis will wait that long though once Conatus starts its phase 2b LC trial in a few months time.
icon url

realfast95

02/06/17 8:50 AM

#1135 RE: fishhunter #1132

Correction: Bret Jensen has sold calls, not directly shorted.
I don't know if the contract writers Short shares, or Buy shares as a hedge.

We won't know until all the institutional investors report, to see that the holders got out on the Novartis announcement or continue to hold.

Congrats for holding through the unknown.

I haven't traded Bio stocks really too much until the last couple of months. So I an learning as I go. Have already made 4 mistakes.
Most of which is not selling on blips and buying back lower.